US Stock MarketDetailed Quotes

Viking Therapeutics (VKTX)

Watchlist
  • 31.880
  • -2.460-7.16%
Close Jan 15 16:00 ET
  • 32.270
  • +0.390+1.22%
Pre 04:50 ET
3.60BMarket Cap-15.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viking Therapeutics (VKTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
169.62%98.56M
118.99%74.57M
62.79%55.47M
49.68%150.92M
57.89%46.24M
34.08%36.56M
43.45%34.05M
65.91%34.07M
43.31%100.83M
44.38%29.29M
Selling and administrative expenses
-37.49%8.61M
40.21%14.42M
41.20%14.08M
33.11%49.28M
73.64%15.25M
54.97%13.77M
4.70%10.29M
4.63%9.97M
129.64%37.02M
113.96%8.78M
-General and administrative expense
-37.49%8.61M
40.21%14.42M
41.20%14.08M
33.11%49.28M
73.64%15.25M
54.97%13.77M
4.70%10.29M
4.63%9.97M
129.64%37.02M
113.96%8.78M
Research and development costs
294.79%89.95M
153.07%60.15M
71.73%41.39M
59.30%101.64M
51.14%30.99M
23.97%22.79M
70.79%23.77M
118.96%24.1M
17.65%63.81M
26.73%20.5M
Operating profit
-169.62%-98.56M
-118.99%-74.57M
-62.79%-55.47M
-49.68%-150.92M
-57.89%-46.24M
-34.08%-36.56M
-43.45%-34.05M
-65.91%-34.07M
-43.31%-100.83M
-44.38%-29.29M
Net non-operating interest income expense
-32.53%7.76M
-23.67%9.01M
46.49%9.84M
173.55%40.85M
131.20%10.82M
143.23%11.51M
161.40%11.8M
567.69%6.72M
875.95%14.93M
546.41%4.68M
Non-operating interest income
-32.60%7.77M
-23.58%9.03M
46.24%9.86M
172.57%40.94M
130.43%10.84M
143.63%11.53M
159.95%11.82M
552.32%6.75M
845.25%15.02M
542.90%4.71M
Total other finance cost
-66.67%8K
33.33%24K
-14.29%24K
6.82%94K
-7.69%24K
1,100.00%24K
-43.75%18K
0.00%28K
49.15%88K
225.00%26K
Other net income (expense)
-90.83%10K
100.00%4K
112K
1K
109K
2K
Gain on sale of security
-90.83%10K
100.00%4K
----
--112K
--1K
--109K
--2K
----
----
----
Income before tax
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
Income tax
Net income
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
Net income continuous Operations
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
Minority interest income
Net income attributable to the parent company
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-264.02%-90.79M
-194.66%-65.56M
-66.80%-45.63M
-28.02%-109.96M
-43.94%-35.42M
-10.68%-24.94M
-15.73%-22.25M
-40.06%-27.36M
-24.73%-85.9M
-25.80%-24.61M
Basic earnings per share
-268.18%-0.81
-190.00%-0.58
-57.69%-0.41
-10.99%-1.01
-28.00%-0.32
4.35%-0.22
-5.26%-0.2
-4.00%-0.26
-1.11%-0.91
3.85%-0.25
Diluted earnings per share
-268.18%-0.81
-190.00%-0.58
-57.69%-0.41
-10.99%-1.01
-28.00%-0.32
4.35%-0.22
-5.26%-0.2
-4.00%-0.26
-1.11%-0.91
3.85%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 169.62%98.56M118.99%74.57M62.79%55.47M49.68%150.92M57.89%46.24M34.08%36.56M43.45%34.05M65.91%34.07M43.31%100.83M44.38%29.29M
Selling and administrative expenses -37.49%8.61M40.21%14.42M41.20%14.08M33.11%49.28M73.64%15.25M54.97%13.77M4.70%10.29M4.63%9.97M129.64%37.02M113.96%8.78M
-General and administrative expense -37.49%8.61M40.21%14.42M41.20%14.08M33.11%49.28M73.64%15.25M54.97%13.77M4.70%10.29M4.63%9.97M129.64%37.02M113.96%8.78M
Research and development costs 294.79%89.95M153.07%60.15M71.73%41.39M59.30%101.64M51.14%30.99M23.97%22.79M70.79%23.77M118.96%24.1M17.65%63.81M26.73%20.5M
Operating profit -169.62%-98.56M-118.99%-74.57M-62.79%-55.47M-49.68%-150.92M-57.89%-46.24M-34.08%-36.56M-43.45%-34.05M-65.91%-34.07M-43.31%-100.83M-44.38%-29.29M
Net non-operating interest income expense -32.53%7.76M-23.67%9.01M46.49%9.84M173.55%40.85M131.20%10.82M143.23%11.51M161.40%11.8M567.69%6.72M875.95%14.93M546.41%4.68M
Non-operating interest income -32.60%7.77M-23.58%9.03M46.24%9.86M172.57%40.94M130.43%10.84M143.63%11.53M159.95%11.82M552.32%6.75M845.25%15.02M542.90%4.71M
Total other finance cost -66.67%8K33.33%24K-14.29%24K6.82%94K-7.69%24K1,100.00%24K-43.75%18K0.00%28K49.15%88K225.00%26K
Other net income (expense) -90.83%10K100.00%4K112K1K109K2K
Gain on sale of security -90.83%10K100.00%4K------112K--1K--109K--2K------------
Income before tax -264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M
Income tax
Net income -264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M
Net income continuous Operations -264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M
Minority interest income
Net income attributable to the parent company -264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -264.02%-90.79M-194.66%-65.56M-66.80%-45.63M-28.02%-109.96M-43.94%-35.42M-10.68%-24.94M-15.73%-22.25M-40.06%-27.36M-24.73%-85.9M-25.80%-24.61M
Basic earnings per share -268.18%-0.81-190.00%-0.58-57.69%-0.41-10.99%-1.01-28.00%-0.324.35%-0.22-5.26%-0.2-4.00%-0.26-1.11%-0.913.85%-0.25
Diluted earnings per share -268.18%-0.81-190.00%-0.58-57.69%-0.41-10.99%-1.01-28.00%-0.324.35%-0.22-5.26%-0.2-4.00%-0.26-1.11%-0.913.85%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -